Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK5 | Q00535 | 13/20 | 0.48 |
| ▸ | CDK5R1 | Q15078 | 13/20 | 0.48 |
| ▸ | CCNA2 | P20248 | 6/20 | 0.43 |
| ▸ | CDK2 | P24941 | 6/20 | 0.43 |
| ▸ | CCNA1 | P78396 | 6/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.42 |
| ▸ | ACKR3 | P25106 | 2/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5337648 | 0.91 | CDK5 (0.53) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL5342321 | 0.90 | CDK5 (0.48) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL5343095 | 0.90 | ACKR3 (0.48) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL5338265 | 0.90 | CDK5 (0.59) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL5345598 | 0.90 | CDK5 (0.59) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL5347573 | 0.90 | CDK5 (0.53) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| Hydrochloric Acid SCHEMBL5337336 | 0.89 | CDK5 (0.58) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL5342527 | 0.89 | CDK5 (0.60) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL5348188 | 0.88 | CDK5 (0.48) | CDK5CDK5R1CCNA2CDK2CCNA1 | |
| SCHEMBL5343245 | 0.88 | CDK5 (0.48) | CDK5CDK5R1CCNA2CDK2CCNA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1309589-A2 | UREA COMPOUNDS AND METHODS OF USES | Amgen Inc. (US) | 2003-05-14 | — | — | EP | disclosed |
| WO-2002014311-A2 | UREA COMPOUNDS AND METHODS OF USES | AMGEN INC. (US) | 2002-02-21 | — | — | WO | disclosed |